Beximco Pharmaceuticals (DHA:BXPHARMA) Accounts Payable & Accrued Expense : BDT6,819 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Accounts Payable & Accrued Expense?

Beximco Pharmaceuticals's quarterly accounts payable & accrued expense declined from Mar. 2023 (BDT3,852 Mil) to Jun. 2023 (BDT2,474 Mil) but then increased from Jun. 2023 (BDT2,474 Mil) to Dec. 2023 (BDT6,819 Mil).

Beximco Pharmaceuticals's annual accounts payable & accrued expense increased from Jun. 2021 (BDT1,207 Mil) to Jun. 2022 (BDT1,667 Mil) and increased from Jun. 2022 (BDT1,667 Mil) to Jun. 2023 (BDT2,474 Mil).

Beximco Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Beximco Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Accounts Payable & Accrued Expense Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

838.67

1,026.51

1,206.53

1,666.67

2,473.86

Beximco Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,862.31	5,251.05	3,852.14	2,473.86	6,819.12

Beximco Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines